Nuvectis Pharma
Nuvectis Pharma initiates phase 1a NXP900 clinical trial
September 13, 2023Research and Development Cancer, Nuvectis Pharma, Oncology, clinical trial
Clinical stage biopharmaceutical company Nuvectis Pharma has announced the initiation of a phase 1a dose escalation clinical study of NXP900, …
